ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2010 Financial Results (Business Wire)

WALTHAM, Mass.----ImmunoGen, Inc. , a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload technology, today announced financial results for the three-month period ended December 31, 2009 – the second quarter of the Company’s 2010 fiscal year .